Fingerprint
Dive into the research topics of 'Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
Jorge E. Cortes, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio A. Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang
Research output: Contribution to journal › Review article › peer-review
21
Scopus
citations